Transcoronary transplantation of progenitor cells after myocardial infarction

Article Abstract:

A study investigates whether intracoronary infusion of progenitor cells into the infarct-related artery at least three months after myocardial infarction improves global and regional left ventricular function. Evidence suggests that intracoronary infusion of progenitor cells is safe and feasible in patients with healed myocardial infarction, and that transplantation of bone marrow (BMC) is associated with moderate but significant improvement in the left ventricular ejection fraction after three months.

Author: Dimmeler, Stefanie, Zeiher, Andreas M., Abolmaali, Nasreddin D., Schachinger, Volker, Assmus, Birgit, Tonn, Torsten, Honold, Jorg, Britten, Martina B., Fischer-Rasokat, Ulrich, Lehmann, Ralf, Teupe, Claudius, Pistorius, Katrin, Martin, Hans
New England States, Care and treatment, Cells, Cardiac patients, Cell transplantation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prognostic value of placental growth factor in patients with acute chest pain

Article Abstract:

Increased blood levels of a protein called placental growth factor may be a risk factor for heart attack in patients with chest pain from coronary artery disease, according to a study of 1,173 patients. Those with elevated placental growth factor were three times more likely to have a heart attack within 30 days than other patients. Placental growth factor may increase during inflammation.

Author: Simoons, Maarten L., Hamm, Christian W., Heeschen, Christopher, Dimmeler, Stefanie, Zeiher, Andreas M., Fichtlscherer, Stephan, Berger, Juergen
Growth factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Soluble CD40 ligand in acute coronary syndromes

Article Abstract:

Increased blood levels of soluble CD40 ligand in patients with coronary artery disease is a risk factor for heart attack and death, according to a study of 1,088 patients. This protein occurs on cells involved in blood clotting and is shed into the bloodstream when these cells are activated. It can cause inflammation in this state, which can worsen the patient's prognosis.

Author: Boersma, Eric, Hamm, Christian W., Heeschen, Christopher, Dimmeler, Stefanie, Brand, Marcel J. van den, Zeiher, Andreas M., Simoons, Marten L.
Physiological aspects, Coronary heart disease, Ligands (Biochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Heart attack, Risk factors
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.